appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Lupin Ltd
LUPIN
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Company Profile
Lupin Limited is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world.
Brands
Investor PresentationView older
View Older PresentationsBrands
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Zydus Lifesciences Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Decreased Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has decreased by 2.11%
Recent NewsAll news
Healthcare at new high; Lupin, Glenmark among 5 stocks for up to 15% upside
6 hours ago•Business Standard
Lupin stock hits eight-year high at Rs 1,749 on healthy earnings outlook
19 hours ago•Business Standard
Lupin stock rallies 7%, hits multi-year high on healthy earnings outlook
1 day ago•Business Standard
Recent EventsAll events
Record Date
Lupin Limited has fixed Tuesday, July 16, 2024, as the 'Record Date' for the purpose of ascertaining the Shareholders who will be entitled to payment of dividend, if declared at the Annual General Meeting. | Download
Lupin Limited has fixed Tuesday, July 16, 2024, as the 'Record Date' for the purpose of ascertaining the Shareholders who will be entitled to payment of dividend, if declared at the Annual General Meeting. | Download
Cash Dividend
Final • Div/Share: ₹ 4
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant